Bausch + Lomb has initiated the first clinical trial for its Technolas Teneo excimer laser for myopia and myopic astigmatism correction surgery, the company announced in a press release.
The multicenter, prospective, open-label, nonrandomized study will evaluate the safety and efficacy of the Technolas Teneo 317 (model 2) excimer laser in LASIK surgery.
“This is an exciting milestone for our organization, as it’s the first step on the road to filing for regulatory approval for the Teneo laser in the United States,” Chuck Hess, vice president and general manager, U.S. Surgical,
Uncategorized